Clinical trial
A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
NCT00420186 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00420186 |
|---|---|
| Title | A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin |
| Official title | A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-690514 in Combination With Paclitaxel and Carboplatin for Patients With Advanced or Metastatic Solid Tumors |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer (Solid Tumors) |
| Intervention type | Drug |
| Interventions | BMS-690514 |
| Enrollment | 37 |
| Start date | Oct 1, 2007 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Jan 9, 2007 |
| Last update posted | Sep 30, 2016 |
| Countries | Canada, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: